Skip to main content
Premium Trial:

Request an Annual Quote

Enticed by Offers, Lion Plans to Sell Bioinformatics Business

NEW YORK, April 20 (GenomeWeb News) - Lured by several unsolicited acquisition offers, Lion Bioscience plans to sell its bioinformatics business by the end of September, the company said today.


The company is currently putting together a structured public tender offer for potential buyers. According to Lion, several companies have shown interest in purchasing the bioinformatics business, especially its SRS product. For example, last month, during Lion's annual shareholders' meeting, an investor announced that a pair of venture capital firms on whose behalf he was speaking may soon offer to take over the company.


A possible management buyout, suggested earlier this year and voted for during the shareholders' meeting, will be postponed until the tender offer is in place.


In conjunction with the planned sale of the bioinformatics business, Thure Etzold, inventor of SRS and currently CEO of Lion, will resign from the board of management in the near future.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.